Seftel, M. D. (2020). Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection. CMAJ.
Citación estilo ChicagoSeftel, Matthew D. "Additional Safety Consideration for Azithromycin in the Management of SARS-CoV-2 Infection." CMAJ 2020.
Cita MLASeftel, Matthew D. "Additional Safety Consideration for Azithromycin in the Management of SARS-CoV-2 Infection." CMAJ 2020.
Precaución: Estas citas no son 100% exactas.